Full Press Release Details
BOSTON, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced that management will participate in the following upcoming investor conferences:
Guggenheim’s 4th Annual Immunology and Neurology Conference Fireside chat on Monday, November 14, 2022 at 10:45 a.m. ET
Piper Sandler 34th Annual Healthcare Conference Fireside chat on Tuesday, November 29, 2022 at 1:00 p.m. ET
The events will be available via live webcast through the Events & Presentations page of the Investors + Media section of the company’s website at www.praxismedicines.com. Replays of the webcasts will be available on Praxis’ website for 30 days following the events.